Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária

Detalhes bibliográficos
Autor(a) principal: Souza, Conceicao Pinheiro De [UNIFESP]
Data de Publicação: 2019
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=7699099
https://repositorio.unifesp.br/handle/11600/59625
Resumo: Background: The immunogenicity of antigens from blood group systems is now better understood by the availability of knowledge of the genetic basis of the proteins involved, molecular orientation in the erythrocyte membrane and the nature of cellular immune responses. Aims: To investigate the association of the HLA-DRB1 alleles in the selective immune response against the antigens of the RH, KEL, FY, JK and MNS systems, either in the sensitization against one or multiple erythrocyte antigens, as well as to verify if there is any allele associated with a protective effect alloimmunization. Methods: This study that analyzed blood samples from 215 patients alloimmunized against antigens from the RH, KEL, FY, JK and MNS systems and compared them with three control groups: 100 blood donors, 101 non-alloimmunized patients and 174,015 candidates for bone marrow donation. Alloantibodies were identified by gel methodology and confirmed by erythrocyte phenotyping. The HLA-DRB1 genotyping was performed by the PCR- SSO technique, using Luminex technology. The GraphPad InStat software was used for statistical analysis. The in silico analysis was performed using the NetMHCIIpan-3.2 server, able to predict the possibilities of interaction between the amino acid sequences of the RhD, RhCE, KEL, FY, JK and MNS proteins and the polymorphic pockets residues of the DRB1 molecules. Alignment was used to evaluate the similarity between the residues located along the β1 domain of the HLA-DR molecules, which showed strong interaction with the anchor peptides derived from the antigenic proteins. Results: Among the multialoimmunized patients, the anti-D+C association was the most frequent, present in 90.3% of the associations with anti-D. Statistical analysis indicated the association between the HLA-DRB1*01 allele and the anti-C and anti-Jka alloimmunizations, as well as the HLA-DRB1*15 allele in the comparison between patients with single and multiple clinically relevant red blood cell antibodies and bone marrow donors control group. This latter finding was due to the association of the HLA-DRB1*15 allele with the anti-D, -C, -E and -K aloimmunizations. The in silico analysis confirmed the associations shown, demonstrating a strong interaction between the DRB1*01 molecule and the anchor peptides derived from the RhCe and JK proteins, and between the DRB1*15 molecule and the major anchor peptides derived from RhD, RhCe, RhcE and KEL proteins, which contained the polymorphic determinants of D, C, E and K antigens in their sequences or adjacent regions. Although the HLA-DRB1*11 allele had a higher frequency among bone marrow donors, apparently exerting a protective effect on alloimmunization, in silico analysis refuted this finding. While the protein sequence containing the 193M polymorphism of the K antigen showed high histocompatibility promiscuity with numerous DRB1 molecules, the sequence containing the 280D polymorphism of the Jka antigen showed interaction only with the DRB1*01 molecule, and the sequences containing the polymorphisms of Fya (42G ) and S (29M) showed weak binding with few molecules. Conclusion: The anti-D+C association, whose frequency is high among alloimmunized patients, could be explained by two factors: the high phenotypic frequency of D and C antigens in the population and the interaction capacity of several DRB1 molecules, such as DRB1*12:01, *15:01 and *15:03, with the anchor peptides derived from the RhD and RhCe proteins, which contained 60I, 68S and 103S polymorphisms common to D and C antigens. The difference in reactivity between the DRB1 molecules and the JK, FY and MNS proteins observed in the in silico analysis seems to be directly associated with the low immunogenicity of the Jka, Fya and S antigens, compared to the D, C, E and K antigens. In silico analysis of blood group proteins may be a practical resource, at no additional cost to the laboratory, which allows a greater understanding of the interaction capacity between antigenic peptides and HLA-DR molecules in the presentation process and consequent production of alloantibodies.
id UFSP_f2efd8b7707478708fecc3dfe22175bf
oai_identifier_str oai:repositorio.unifesp.br/:11600/59625
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitáriaAssociation between HLA-DRB1 alleles and red blood cell alloimmunization.ErythrocytesAlloimmunizationAllelesHLA-DRB1Analysis In SilicoDRB1 MoleculeAnchor PeptideEritrócitosAloimunizaçãoAlelosHLA-DRB1Análise In SilicoMolécula DRB1Peptídeo ÂncoraBackground: The immunogenicity of antigens from blood group systems is now better understood by the availability of knowledge of the genetic basis of the proteins involved, molecular orientation in the erythrocyte membrane and the nature of cellular immune responses. Aims: To investigate the association of the HLA-DRB1 alleles in the selective immune response against the antigens of the RH, KEL, FY, JK and MNS systems, either in the sensitization against one or multiple erythrocyte antigens, as well as to verify if there is any allele associated with a protective effect alloimmunization. Methods: This study that analyzed blood samples from 215 patients alloimmunized against antigens from the RH, KEL, FY, JK and MNS systems and compared them with three control groups: 100 blood donors, 101 non-alloimmunized patients and 174,015 candidates for bone marrow donation. Alloantibodies were identified by gel methodology and confirmed by erythrocyte phenotyping. The HLA-DRB1 genotyping was performed by the PCR- SSO technique, using Luminex technology. The GraphPad InStat software was used for statistical analysis. The in silico analysis was performed using the NetMHCIIpan-3.2 server, able to predict the possibilities of interaction between the amino acid sequences of the RhD, RhCE, KEL, FY, JK and MNS proteins and the polymorphic pockets residues of the DRB1 molecules. Alignment was used to evaluate the similarity between the residues located along the β1 domain of the HLA-DR molecules, which showed strong interaction with the anchor peptides derived from the antigenic proteins. Results: Among the multialoimmunized patients, the anti-D+C association was the most frequent, present in 90.3% of the associations with anti-D. Statistical analysis indicated the association between the HLA-DRB1*01 allele and the anti-C and anti-Jka alloimmunizations, as well as the HLA-DRB1*15 allele in the comparison between patients with single and multiple clinically relevant red blood cell antibodies and bone marrow donors control group. This latter finding was due to the association of the HLA-DRB1*15 allele with the anti-D, -C, -E and -K aloimmunizations. The in silico analysis confirmed the associations shown, demonstrating a strong interaction between the DRB1*01 molecule and the anchor peptides derived from the RhCe and JK proteins, and between the DRB1*15 molecule and the major anchor peptides derived from RhD, RhCe, RhcE and KEL proteins, which contained the polymorphic determinants of D, C, E and K antigens in their sequences or adjacent regions. Although the HLA-DRB1*11 allele had a higher frequency among bone marrow donors, apparently exerting a protective effect on alloimmunization, in silico analysis refuted this finding. While the protein sequence containing the 193M polymorphism of the K antigen showed high histocompatibility promiscuity with numerous DRB1 molecules, the sequence containing the 280D polymorphism of the Jka antigen showed interaction only with the DRB1*01 molecule, and the sequences containing the polymorphisms of Fya (42G ) and S (29M) showed weak binding with few molecules. Conclusion: The anti-D+C association, whose frequency is high among alloimmunized patients, could be explained by two factors: the high phenotypic frequency of D and C antigens in the population and the interaction capacity of several DRB1 molecules, such as DRB1*12:01, *15:01 and *15:03, with the anchor peptides derived from the RhD and RhCe proteins, which contained 60I, 68S and 103S polymorphisms common to D and C antigens. The difference in reactivity between the DRB1 molecules and the JK, FY and MNS proteins observed in the in silico analysis seems to be directly associated with the low immunogenicity of the Jka, Fya and S antigens, compared to the D, C, E and K antigens. In silico analysis of blood group proteins may be a practical resource, at no additional cost to the laboratory, which allows a greater understanding of the interaction capacity between antigenic peptides and HLA-DR molecules in the presentation process and consequent production of alloantibodies.A imunogenicidade dos antígenos dos sistemas de grupos sanguíneos é melhor compreendida, atualmente, graças à disponibilidade do conhecimento da base genética das proteínas envolvidas, à orientação molecular na membrana eritrocitária e à natureza das respostas imunes celulares. Objetivos: Investigar a associação dos alelos HLA-DRB1 na resposta imune seletiva contra os antígenos dos sistemas RH, KEL, FY, JK e MSN, na sensibilização contra um ou múltiplos antígenos eritrocitários, bem como verificar se existe algum alelo associado a um efeito protetor à aloimunização. Pacientes e Métodos: Este estudo analisou amostras de sangue de 215 pacientes aloimunizados contra antígenos dos sistemas RH, KEL, FY, JK e MNS, e as comparou com três grupos controle: 100 doadores de sangue, 101 pacientes não aloimunizados e 174.015 candidatos à doação de medula óssea. Os aloanticorpos foram identificados pela metodologia em gel e confirmados pela fenotipagem eritrocitária. A genotipagem HLA-DRB1 foi realizada pela técnica de PCR-SSO, utilizando tecnologia Luminex. O Software GraphPad InStat foi utilizado na análise estatística. A análise in silico foi realizada utilizando o servidor NetMHCIIpan-3.2, capaz de prever as possibilidades de interação entre as sequências de aminoácidos das proteínas RhD, RhCE, KEL, FY, JK e MNS e os resíduos dos bolsos polimórficos das moléculas DRB1. O alinhamento foi utilizado para avaliar a similaridade existente entre os resíduos localizados ao longo do domínio β1 das moléculas HLA-DR, que apresentaram interação forte com os peptídeos âncora derivados das proteínas antigênicas. Resultados: Dentre os pacientes multialoimunizados, a associação anti-D+C foi a mais frequente, presente em 90,3% das associações com anti-D. A análise estatística apontou a associação do alelo HLA-DRB1*01 com as aloimunizações anti-C e anti-Jka, bem como do alelo HLA-DRB1*15 na comparação entre os pacientes uni e multialoimunizados e os doadores de medula óssea. Esta última relação ocorreu em virtude da associação deste alelo com as aloimunizações anti-D, -C, -E e –K. A análise in silico confirmou as associações apresentadas, demonstrando uma interação forte entre a molécula DRB1*01 e os peptídeos âncora derivados das proteínas RhCe e JK, e entre a molécula DRB1*15 e os principais peptídeos âncora derivados das proteínas RhD, RhCe, RhcE e KEL, que continham, em sua sequência ou nas regiões adjacentes, o(s) determinante(s) polimórfico(s) dos antígenos D, C, E e K. Embora o alelo HLA-DRB1*11 apresentasse maior frequência entre os doadores de medula óssea, aparentemente exercendo um efeito protetor à aloimunização, a análise in silico refutou este achado. Enquanto a sequência proteica contendo o determinante polimórfico 193M do antígeno K apresentou alta indiscriminação de histocompatibilidade com numerosas moléculas DRB1, a sequência contendo o determinante polimórfico 280D do antígeno Jka só apresentou interação com a molécula DRB1*01, e as sequências contendo os determinantes polimórficos de Fya (42G) e S (29M) apresentaram interação fraca com poucas moléculas. Discussão e Conclusão: A associação anti-D+C, frequentemente elevada, pôde ser explicada tanto em função da frequência fenotípica dos antígenos D e C na população, como pela capacidade de interação de variadas moléculas DRB1, a exemplo de DRB1*12:01, *15:01 e *15:03, com os peptídeos âncora derivados das proteínas RhD e RhCe, que continham os determinantes polimórficos 60I, 68S e 103S, comuns aos antígenos D e C. A diferença de reatividade entre as moléculas DRB1 e as proteínas JK, FY e MNS, observada na análise in silico, parece diretamente associada com a baixa imunogenicidade dos antígenos Jka, Fya e S, comparada aos antígenos D, C, E e K. A análise in silico das proteínas de grupo sanguíneo pode ser um recurso prático e sem custos adicionais ao laboratório, que permite uma maior compreensão da capacidade de interação entre os peptídeos antigênicos e as moléculas HLA-DR, no processo de apresentação e consequente produção de anticorpos eritrocitários.Dados abertos - Sucupira - Teses e dissertações (2019)Universidade Federal de São Paulo (UNIFESP)Bordin, Jose Orlando [UNIFESP]http://lattes.cnpq.br/4235368036147314http://lattes.cnpq.br/4350403289378059Universidade Federal de São Paulo (UNIFESP)Souza, Conceicao Pinheiro De [UNIFESP]2021-01-19T16:34:06Z2021-01-19T16:34:06Z2019-02-13info:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/publishedVersion122 p.application/pdfhttps://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=7699099SOUZA, Conceição Pinheiro. Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária. 2019. 122f. Tese (Doutorado em Hematologia) – Escola Paulista de Medicina, Universidade Federal de São Paulo. São Paulo, 2019.Conceição Pinheiro de Souza -A.pdfhttps://repositorio.unifesp.br/handle/11600/59625porSão Pauloinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-03T04:00:34Zoai:repositorio.unifesp.br/:11600/59625Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-03T04:00:34Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
Association between HLA-DRB1 alleles and red blood cell alloimmunization.
title Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
spellingShingle Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
Souza, Conceicao Pinheiro De [UNIFESP]
Erythrocytes
Alloimmunization
Alleles
HLA-DRB1
Analysis In Silico
DRB1 Molecule
Anchor Peptide
Eritrócitos
Aloimunização
Alelos
HLA-DRB1
Análise In Silico
Molécula DRB1
Peptídeo Âncora
title_short Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
title_full Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
title_fullStr Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
title_full_unstemmed Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
title_sort Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária
author Souza, Conceicao Pinheiro De [UNIFESP]
author_facet Souza, Conceicao Pinheiro De [UNIFESP]
author_role author
dc.contributor.none.fl_str_mv Bordin, Jose Orlando [UNIFESP]
http://lattes.cnpq.br/4235368036147314
http://lattes.cnpq.br/4350403289378059
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Souza, Conceicao Pinheiro De [UNIFESP]
dc.subject.por.fl_str_mv Erythrocytes
Alloimmunization
Alleles
HLA-DRB1
Analysis In Silico
DRB1 Molecule
Anchor Peptide
Eritrócitos
Aloimunização
Alelos
HLA-DRB1
Análise In Silico
Molécula DRB1
Peptídeo Âncora
topic Erythrocytes
Alloimmunization
Alleles
HLA-DRB1
Analysis In Silico
DRB1 Molecule
Anchor Peptide
Eritrócitos
Aloimunização
Alelos
HLA-DRB1
Análise In Silico
Molécula DRB1
Peptídeo Âncora
description Background: The immunogenicity of antigens from blood group systems is now better understood by the availability of knowledge of the genetic basis of the proteins involved, molecular orientation in the erythrocyte membrane and the nature of cellular immune responses. Aims: To investigate the association of the HLA-DRB1 alleles in the selective immune response against the antigens of the RH, KEL, FY, JK and MNS systems, either in the sensitization against one or multiple erythrocyte antigens, as well as to verify if there is any allele associated with a protective effect alloimmunization. Methods: This study that analyzed blood samples from 215 patients alloimmunized against antigens from the RH, KEL, FY, JK and MNS systems and compared them with three control groups: 100 blood donors, 101 non-alloimmunized patients and 174,015 candidates for bone marrow donation. Alloantibodies were identified by gel methodology and confirmed by erythrocyte phenotyping. The HLA-DRB1 genotyping was performed by the PCR- SSO technique, using Luminex technology. The GraphPad InStat software was used for statistical analysis. The in silico analysis was performed using the NetMHCIIpan-3.2 server, able to predict the possibilities of interaction between the amino acid sequences of the RhD, RhCE, KEL, FY, JK and MNS proteins and the polymorphic pockets residues of the DRB1 molecules. Alignment was used to evaluate the similarity between the residues located along the β1 domain of the HLA-DR molecules, which showed strong interaction with the anchor peptides derived from the antigenic proteins. Results: Among the multialoimmunized patients, the anti-D+C association was the most frequent, present in 90.3% of the associations with anti-D. Statistical analysis indicated the association between the HLA-DRB1*01 allele and the anti-C and anti-Jka alloimmunizations, as well as the HLA-DRB1*15 allele in the comparison between patients with single and multiple clinically relevant red blood cell antibodies and bone marrow donors control group. This latter finding was due to the association of the HLA-DRB1*15 allele with the anti-D, -C, -E and -K aloimmunizations. The in silico analysis confirmed the associations shown, demonstrating a strong interaction between the DRB1*01 molecule and the anchor peptides derived from the RhCe and JK proteins, and between the DRB1*15 molecule and the major anchor peptides derived from RhD, RhCe, RhcE and KEL proteins, which contained the polymorphic determinants of D, C, E and K antigens in their sequences or adjacent regions. Although the HLA-DRB1*11 allele had a higher frequency among bone marrow donors, apparently exerting a protective effect on alloimmunization, in silico analysis refuted this finding. While the protein sequence containing the 193M polymorphism of the K antigen showed high histocompatibility promiscuity with numerous DRB1 molecules, the sequence containing the 280D polymorphism of the Jka antigen showed interaction only with the DRB1*01 molecule, and the sequences containing the polymorphisms of Fya (42G ) and S (29M) showed weak binding with few molecules. Conclusion: The anti-D+C association, whose frequency is high among alloimmunized patients, could be explained by two factors: the high phenotypic frequency of D and C antigens in the population and the interaction capacity of several DRB1 molecules, such as DRB1*12:01, *15:01 and *15:03, with the anchor peptides derived from the RhD and RhCe proteins, which contained 60I, 68S and 103S polymorphisms common to D and C antigens. The difference in reactivity between the DRB1 molecules and the JK, FY and MNS proteins observed in the in silico analysis seems to be directly associated with the low immunogenicity of the Jka, Fya and S antigens, compared to the D, C, E and K antigens. In silico analysis of blood group proteins may be a practical resource, at no additional cost to the laboratory, which allows a greater understanding of the interaction capacity between antigenic peptides and HLA-DR molecules in the presentation process and consequent production of alloantibodies.
publishDate 2019
dc.date.none.fl_str_mv 2019-02-13
2021-01-19T16:34:06Z
2021-01-19T16:34:06Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=7699099
SOUZA, Conceição Pinheiro. Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária. 2019. 122f. Tese (Doutorado em Hematologia) – Escola Paulista de Medicina, Universidade Federal de São Paulo. São Paulo, 2019.
Conceição Pinheiro de Souza -A.pdf
https://repositorio.unifesp.br/handle/11600/59625
url https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=7699099
https://repositorio.unifesp.br/handle/11600/59625
identifier_str_mv SOUZA, Conceição Pinheiro. Associação entre os alelos HLA-DRB1 e a aloimunização eritrocitária. 2019. 122f. Tese (Doutorado em Hematologia) – Escola Paulista de Medicina, Universidade Federal de São Paulo. São Paulo, 2019.
Conceição Pinheiro de Souza -A.pdf
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 122 p.
application/pdf
dc.coverage.none.fl_str_mv São Paulo
dc.publisher.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
publisher.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268450757935104